Abstract

  The present work encompasses the development and validation of UV Spectrophotometric method for the concurrent estimation of Mupirocin (MUP) and Methylprednisolone (MP) in their combined dosage form. The method developed herein involves Second order derivative method. The wavelength selected for quantification were 263 nm for Methylprednisolone (zero-crossing for Mupirocin) and 289 nm for Mupirocin (zero-crossing for Methylprednisolone). The drugs follow linearity in the concentration range 6 - 14 μg/ml for MP and 120 - 280 μg/ml for MUP respectively. The analytical method was validated as per ICH, Q2, (R1) guideline and all the result were found under the acceptance criteria. The developed method was simple, economic, accurate, precise and can be used for estimation of Mupirocin and Methylprednisolone in their combined dosage form.

Keywords: Mupirocin; Methylprednisolone; UV Spectrophotometry; Second-order Derivative Method; ICH Guidelines

References

1. Tripathi KD. Essentials of Medical pharmacology, 7th Ed. Jaypee Brothers Medical Publishers, New Delhi (2013): 282.
2. J Beale and J Block. Wilson and Gissvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, 12th Edn, Wolters Kluwer, New Delhi (2011): 322-860.
3. “Mechanism of action of Mupirocin”.
4. T Lemke., et al. Principles of Medicinal Chemistry, 6th Edn, Wolters Kluwer, New Delhi (2008): 892-1081,.
5. L Laurenc., et al. The Pharmacological basis of Therapeutics, McGraw Hill, Newyork, U.S.A. (2001): 594-1603.
6. “Drug profile of Methylprednisolone”.
7. Bana A., et al. “Analytical method development and validation for simultaneous estimation of Halobetasol Propionate and Mupirocin in the ratio of 1:40 by U.V. Spectroscopy and RP-HPLC method”. International Journal of Pharmaceutical Science and Research3 (2019): 1392-1401.
8. Shende M and Sayyad H. “Development and validation of spectroscopic analytical method for simultaneous estimation of Mupirocin and Satranidazole in bulk and topical formulation”. International Journal of Pharmacy and Pharmaceutical Science1 (2017): 225-240.
9. Rele R. “Development and validation of analytical method by RP-HPLC technique for determination of Mupirocin Calcium in pharmaceutical dosage form”. Journal of Chemical and Pharmaceutical Research10 (2017): 249-253.
10. Aradhya V., et al. “Development and validation of UV spectroscopic method for estimation of Methylprednisolone in bulk and pharmaceutical formulation”. World Journal of Pharmacy and Pharmaceutical Science5 (2018): 498-503.
11. Bhandari J., et al. “Spectrophotometric method development and validation for estimation of Gatifloxacin and Prednisolone Acetate in bulk and eye drop”. International Journal of Pharmaceutical Research Scholars1 (2018): 107-112.
12. Chhajed S., et al. “Densitometric development and validation of Mupirocin in ointment dosage form”. Der Pharmacia Sinica6 (2013): 10-15.
13. Rubenick J., et al. “Preparation of Mupirocin loaded nanocapsule using essential oil of rosemary”. Brazilian Journal of Pharmaceutical Sciences1 (2017): 1-11.
14. Echevarr L., et al. “Development and validation of a liquid chromatographic method for in vitro Mupirocin quantification in both skin layers and percutaneous penetration studies”. Journal of Chromatography 796 (2003): 233-241.
15. Siddiraju S., et al. “A novel LC–MS/MS assay for methylprednisolone in human plasma and its pharmacokinetic application”. Asian Journal of Pharmaceutical Science 11 (2016): 459-468.
16. Nowakowska J., et al. “A simple TLC and HPTLC method for separation of selected steroid drugs”. Central European Journal of Chemistry8 (2013): 1297-1308.
17. Chulksi T and Lamb D. “Colorimetric procedure for determination of Methylprednisolone Hemi dimethylglutarate and Methylprednisolone in Aqueous Solutions”. Journal of Pharmaceutical Science2 (1963): 169-170.

Citation

Citation: Virangi Chudasama., et al. “Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Mupirocin and Methyl Prednisolone in Combined Dosage Form". Acta Scientific Biotechnology 1.10 (2020): 07-12.

Copyright

Copyright: © 2020 Virangi Chudasama., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.